Japan approves world-first iPS cell therapies for heart failure, Parkinsons Conditional approvals speed Japans first iPS ...

A new study published in the journal of Frontiers in Cardiovascular Medicine revealed that Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) were associated with improved left ...

A common class of drugs called anticholinergics might boost risks for heart failure and other dangerous cardiac conditions, a new study says. People taking the largest amounts of anticholinergic drugs ...

Dyne Therapeutics is plotting an approval application for z-rostudirsen in the back half of 2026—a push that will only be bolstered by the departure of controversial CBER chief Vinay Prasad, according ...

XYRA LLC announces that the US Patent and Trademark Office (USPTO) has issued a patent (No. 12,551,706) protecting the use of dose adjusted budiodarone ...

High blood pressure is one of the most common health problems in the world. It affects hundreds of millions of people and is ...

The study confirmed that statins and PCSK9 inhibitors are both very effective at lowering cholesterol. By reducing harmful cholesterol levels, these drugs can significantly lower the risk of heart ...

Before he was born, Penn Edwards was diagnosed with hypoplastic right heart syndrome, a rare congenital heart disease. 16 years later, he and his family are still monitoring his condition, ...

“They may not feel depressed but the trauma was real for all of us who lived through that night. Dancing it out of your system is the most effective way of limiting the ongoing effects of such an ...

XYRA gets US patent protecting use of dose adjusted budiodarone to treat AF, with monitoring to correspondingly reduce/delay risk of stroke and/or congestive heart failure: Los Al ...

Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

Together, we proudly represent a leadership team where independent and capable women make decisions at every level, shaping the future direction of our Credit Union. It is an honour to work alongside ...